indicate that alteration of CD (and possibly of other glycoproteins) transport along the secretory pathway due to increased levels of cell-associated ceramide is an early event in cells undergoing apoptosis. Key words: Caspases / Lysosomes / Protein processing / Protein traffic.
Introduction
Ceramide has been implicated as a pleiotropic second messenger in a number of cellular functions ranging from proliferation and differentiation to senescence and apoptosis (Hannun, 1994; Spiegel et al., 1996) . In normal cells these functions are under sophisticated control and assure maintenance of cellular homeostasis, thus preventing cancer development. The fact that ceramide mediates the apoptotic response to cytotoxic cytokines, ionising radiation and chemotherapeutic drugs in cancer cells (Liu et al., 1997; Kolesnick and Krönke, 1998) justifies the interest to identify its molecular targets as well as the sub-cellular sites where it exerts its action. Anabolic and catabolic reactions leading to ceramide synthesis take place in different compartments of the cell and can be modulated in response to a variety of extra-cellular stimuli (Mathias et al., 1998) . De novo synthesis of ceramide begins on the cytosolic surface of the endoplasmic reticulum; the molecule is then transported to the Golgi apparatus where it can be used for the synthesis of sphingomyelin (SM) and glycosphingolipids (Spence, 1993) . As a product of SM hydrolysis by sphingomyelinases, ceramide can be generated at various sub-cellular sites: neutral sphingomyelinase hydrolyses sphingomyelin of the outer leaflet of the plasma membrane, while acid sphingomyelinase produces ceramide on endosomal-lysosomal membranes (Wiegmann et al., 1994) . Once generated, ceramide may transiently accumulate or be metabolised by phosphorylation, deacylation or glycosylation or be converted back to SM (Spence, 1993; Spiegel et al., 1996; Mathias et al., 1998) .
Apoptotic cell death is a genetically encoded process for the demise of exceeding or altered cells in multi-cellular organisms. Dysregulation of the apoptotic response to extra-cellular stimuli is considered a main factor of resistance to anti-cancer therapy and of tumour progression (Fisher, 1994) . The morphological and biochemical changes that occur in cells undergoing apoptosis are being elucidated. Typical morphological alterations involve the plasma membrane, the cytoskeleton and organelles and result in formation of apoptotic bodies (Arends and Wyllie, 1991) . The most common biochemical alteration that characterises the onset of apoptosis is represented by the activation of caspases, a group of cytosolic proteases (Cohen, 1997) . Regardless of which caspase is activated first, the proteolytic cascade leads to activation of caspase 3 (or equivalent), a central effecter of apoptotic death (Salvesen and Dixit, 1997) . In addition to caspases, other proteases such as lysosomal cathepsins B and D have also been shown to participate in the apoptotic process induced by cytokines or chemotherapeutic drugs (Deiss et al., 1996; Wu et al., 1998; Guicciardi et al., 2000; Foghsgaard et al., 2001; Stoka et al., 2001) . Of note, Heinrich and collaborators have recently shown that endosomal ceramide, generated by acid sphingomyelinase, can specifically bind to the precursor of Cathepsin D (CD) and is able to promote its conversion into mature, enzymatically active single-chain and double-chain molecular forms (Heinrich et al., 1999) . Biogenesis of CD is a multistep process in which the newly-synthesised precursor is subject to post-translational modifications of carbohydrates and peptide backbone during its journey from the endoplasmic reticulum to lysosomes via the Golgi apparatus and endosomes (Hasilik, 1992) . In the present study we asked whether ceramide levels influenced different steps of the transport and processing of proCD in apoptosing cancer cells. As the experimental model of ceramide-induced apoptosis we adopted the human colorectal cancer cell line HT-29. Strikingly, these cells have been reported to be rather resistant to a variety of apoptogenic stimuli (Canman et al., 1992; Merchant et al., 1996) , despite the high levels of neutral SMase activity present on the plasma membrane (Kok et al., 1995) .
Here we show that a brief (2 to 8 h) exposure to the permeant analogue N-acetyl-D-erythro-sphingosine (NAS, also known as C2-ceramide), or to the metabolic inhibitor of glucosylceramide synthase 1-phenyl-2-(decanoylamino)-3-morpholino-1-propanol (PDMP), results in increased levels of endogenous ceramide and in early alterations of the transport and maturation of newly synthesised proCD in HT-29 cells. Clear signs of apoptosis, such as appearance of morphological alterations, DNA fragmentation and cleavage of poly (ADP-ribose)-polymerase (PARP, a substrate of caspase 3), became evident no earlier than 8 h after administration of these drugs and could be abrogated in the presence of caspase inhibitors. From these data we conclude that perturbations of the traffic of proCD, and possibly of other glycoproteins, within the secretory pathway parallel the increases of cellular ceramide levels and do not merely follow the cell death process but rather they precede it.
Results
Ceramide Alters CD Maturation in a Concentrationand Time-Dependent Manner CD is synthesised in the rough endoplasmic reticulum as a di-glycosylated precursor that is transported to the Golgi apparatus and eventually to the endosomal-lysosomal compartments where it is converted into the intermediate single-chain and the double-chain active forms (Hasilik, 1992) . These three molecular species of CD are found in the cell in a proportion that reflects the ratio of their synthesis, transport and accumulation in the organelles of the biosynthetic pathway. The transport and maturation of lysosomal CD in HT-29 cells after a 24 h incubation with various concentrations of NAS were evaluated by Western blotting. Both the 53 kDa proCD and the 48 kDa intermediate single-chain CD accumulated in NAS-treated cells in a concentration-dependent fashion ( Figure 1A and C). Concomitantly a substantial decrease in the accumulation of the double-chain mature CD, as identified by its 31 kDa heavy chain, was observed (Figure 1A) . As assessed densitometrically, the amount of this CD form nearly halved in cells treated for 24 h with 100 µM NAS compared to control cells ( Figure 1C ). The time course of the effect of 100 µM NAS on proCD maturation is shown in Figure 1B . Increased accumulation of proCD was evident after 8 h and it became maximal by 24 h of incubation with NAS. At this time-point increased accumulation of the intermediate CD and reduced accumulation of the double-chain CD were also detected (Figure 1B and D) , according to the data shown in Figure 1A .
To validate the specificity of these effects of NAS we also analysed the consequences on CD transport and maturation of a 24 h treatment with DH-C2 (dihydro-Nacetyl-D-erythro-sphingosine), a permeable analogue of ceramide that lacks the 4 -5 double bond in the long chain and is devoid of biological action (Bielawska et al., 1993) . Furthermore, to better assess the relationship between cellular levels of ceramide and maturation of proCD the cells were treated with PDMP, an inhibitor of glucocerebroside synthase that induces an accumulation of the endogenous sphingolipid precursor ceramide (Li and Ladisch, 1996) . As shown in Figure 2A , DH-C2 did not, whereas PDMP did, affect the transport and maturation of proCD in a manner comparable to that of NAS. A quantitative determination of the way NAS, DH-C2 and PDMP affected the relative proportion of CD molecular forms accumulating in treated cells is reported in Figure 2B . Reproducibility of this result was further confirmed in other independent experiments (see also Figure 7) . From these data it can be concluded that NAS and PDMP similarly affect proCD maturation.
NAS and PDMP Effectively Raise Intracellular Ceramide Levels in HT-29 Cells
Short-chain ceramide analogues can serve as precursors for the synthesis of cellular ceramide (Gomez-Munoz et al., 1995; Rani et al., 1995) , which in turn can accumulate transiently or be metabolised further (Spence, 1993; Strelow et al., 2000) . PDMP, on its own, prevents the utilisation of ceramide for the synthesis of glycosphingolipids (Maceyka and Machamer, 1997) . Thus, the artificial accumulation of cellular ceramide obtained by administration of exogenous ceramide analogues or with metabolic inhibitors of glycosphingolipid biosynthesis is likely to vary with cell type in terms of duration and amount, depending on the ability of the cell to adapt its lipid metabolism. To substantiate a causal relationship between cellular ceramide levels and alterations in proCD transport and maturation it seemed important to assess whether incubation with NAS or PDMP indeed led to a progressive accumulation of this lipid within the cells. Changes in the levels of ceramide during the treatments were measured by the diacylglycerol kinase (DAG-K) assay. In control untreated cells cellular ceramide remained at constant low levels throughout the 24 h incubation (Figure 3 ). Upon treatment Targeting of Cathepsin D in Ceramide-Induced Apoptosis 991 with 100 µM NAS cellular levels of ceramide increased progressively with time of incubation, reaching the maximal value at 24 h (about an 8-fold increase over the control level; Figure 3 ). One hundred µMPDMP treatment elicited at 8 h a comparable increase of cellular ceramide as with NAS (an almost 4-fold increase over the control level) and at 24 h the maximal cellular ceramide levels reached a value of about 6-fold that of control cells (Figure 3) . The fact that in NAS-and in PDMP-treated cultures the time course of proCD accumulation (Figure 2 ) parallels the kinetic of ceramide level increases (Figure 3 ) strongly suggests a link between the two events.
Ceramide Induces Apoptosis in HT-29 Cells
In many cell types intracellular accumulation of ceramide, in response to cytotoxic treatments, has been associated with induction of cell death. In dying cells dramatic changes of cellular morphology involving cytoskeleton organisation and organelles occur. We therefore evaluated in HT-29 cells the possible occurrence of such an effect of increased cellular ceramide levels that could by itself modify the intracellular traffic of CD. Microscopical analysis of haematoxylin-eosin-stained cells revealed the presence of some typical apoptotic features, such as condensation and fragmentation of chromatin in cultures treated for 24 h with 100 µM NAS ( Figure 4A ). As an independent demonstration of ongoing apoptosis, we monitored the cytosolic release of cytochrome c from mitochondria (Liu et al., 1996) , the externalisation of plasma membrane phosphatidylserine (Martin et al., 1995) and the involvement of caspases (Cohen, 1997) in HT-29 cells treated under conditions raising intracellular ceramide levels. As shown in Figure 4B , the treatments with both NAS and PDMP led to cytochrome c release from mitochondria into the cytosolic fractions. Flow cytometric analysis of cells stained with propidium iodide and annexin V-FITC provided additional proof of the occurrence of apoptosis in NAS-treated HT-29 cultures ( Figure 4C ). Importantly, positive annexin V binding was abolished when the incubation with NAS was performed in the presence of the pan-caspase inhibitor ZVAD (Z-Val-AlaAsp-fluoromethylketone, not shown) or of the caspase 3-inhibitor DEVD (Asp-Glu-Val-Asp-fluoromethylketone, Figure 4D ). Altogether these data indicate that ceramide is able to convey the apoptotic signal to mitochondria and that ceramide-induced alteration of plasma membrane symmetry is caspase-dependent.
Classical Hallmarks of NAS-or PDMP-Induced Apoptosis Are Detectable Only after 8 h of Treatment
Alteration of CD transport and maturation became apparent in HT-29 cells treated for 8 h with 100 µM NAS (Figure 1 ), a treatment sufficient to induce a 3.5-fold increase of endogenous ceramide levels (Figure 3 ). In the search for a temporal link between these events and onset of apoptosis, we monitored the kinetic of DNA internucleosomal fragmentation in HT-29 cells treated for up to 48 h with 100 µM NAS. Initial DNA laddering was clearly evidenced in cultures treated with NAS for a period longer than 8 h and it was almost complete by 48 h ( Figure 5A ). An independent time course study of ceramide-induced apoptosis was performed by cytofluorometric analysis of DNA distribution in cells incubated for different periods with NAS or PDMP. This parameter also allowed an objective quantitative estimation of ceramide concentration-and time-dependent cell death. Apoptotic cells were identified on the basis of their reduced content in propidium iodide-labelled DNA (Nicoletti et al., 1991) . Fifteen to 25% apoptotic cells were revealed in cultures treated for 24 h with 75 µM and 100 µM NAS, respectively (not shown). These concentrations of NAS correspond to the ones exerting an inhibitory effect on proCD transport and maturation (see Figure 1A) . We used the most effective concentrations of NAS and PDMP for a time course study on the appearance of apoptotic cells. Hypo-diploid cells were detected in cultures treated for 24 h with 100 µM NAS or PDMP, while they were not apparent at 8 h of treatment ( Figure 5B ). This population of apoptotic cells increased with time of incubation with either drug.
In the search for biochemical signs of apoptosis that could precede the loss of DNA integrity, we assayed the processing of PARP, a 116 kDa protein involved in DNA repair (de Murcia et al., 1994) that is a substrate for effecter caspases such as caspase 3 (Lazebnik et al., 1994) . During apoptosis this protein is cleaved into the 85 kDa and 24 kDa inactive products. We reasoned that if ceramide is able to direct the activation of caspase 3 (Mathias et al., 1998) , then PARP cleavage should reflect an early apoptotic action of ceramide increases. Western blotting of homogenates from HT-29 cells treated with 100 µM NAS or 100 µM PDMP for 4, 8 and 24 h revealed the presence of the PARP cleavage product only in the latter samples ( Figure 6A ). To determine the involvement of caspases in this process we included the caspase 3 irreversible inhibitor DEVD during the treatment with NAS. As shown in Figure 6B PARP cleavage did not occur under this experimental condition. From these data we conTargeting of Cathepsin D in Ceramide-Induced Apoptosis 993 clude that increases in cellular levels of ceramide are cytotoxic for HT-29 cells and that activation of caspases follows these increases.
Ceramide-Dependent Alterations of CD Biogenesis and Transport Precede the Appearance of Classical Biochemical Signs of Apoptosis
CD has been shown to be a good protein reporter of the post-translational events occurring along the exocytic and endocytic pathways (Isidoro et al., 1996) . While proCD is the molecular form associated with the endoplasmic reticulum or the Golgi apparatus, the singlechain intermediate is believed to form within acidic late endosomes and the double-chain molecule to be resident in lysosomes (Hasilik, 1992) . In the Golgi apparatus the oligosaccharide chains of proCD are extensively remodelled to generate the mannose-6-phosphate group that serves for the receptor-mediated transport to endosomes. This reaction prevents the formation of complextype sugars (von Figura and Hasilik, 1986) . The results shown in Figures 1 and 2 indicate that an elevation of ceramide causes the retention of proCD and intermediate single-chain CD in compartments upstream of lysosomes. To better assess the precise site of action of ceramide, we analysed the kinetics of transport and maturation of CD in HT-29 cells pulse-labelled for 15 min with a [ 35 S]methionine/cysteine mixture and chased in fresh medium without or with 100 µM NAS or 100 µM PDMP for up to 8 h, a time sufficient for the protein to reach the lysosomal compartment (Isidoro et al., 1997) . This incubation time with NAS or PDMP was certainly sufficient to produce cellular accumulation of ceramide in treated cells (see Figure 3 ), but not sufficient to provoke the activation of the execution phase of apoptosis (see Figures 4 -6) . At the end of each chase-point, medium and cell extracts were prepared and CD immuno-precipitated and analysed by electrophoresis and fluorography. The effects of NAS and of PDMP on the kinetics of transport and processing of proCD are shown in Figure 7 (see also the densitometric evaluation in panel B) and can be summarised as follows. In control cells proCD is either converted into the intermediate single-chain (starting between 2 and 4 h after synthesis) or secreted into the medium (starting between 1 and 2 h after synthesis) and the double-chain form of CD (only the heavy chain is visible in the gel) becomes clearly evident 4 h after synthesis. In NAS-and in PDMP-treated cells the decline of cellassociated proCD appears much slower and its secretion is greatly slowed down and quantitatively much reduced than in control cultures. Notably, in the presence of NAS the intermediate CD becomes evident at the 4 h chasepoint and the heavy chain of the double-chain form of CD is clearly evident only at the 8 h chase-point. In PDMPtreated cells the intermediate single-chain CD becomes apparent after a 4 h chase and greatly accumulates by 8 h chase, while by this time the double-chain CD is only slightly detectable. Therefore, both NAS and PDMP affected the early phases of CD biogenesis causing a delayed processing and a reduced secretion of the precursor. Still, while in NAS-treated cells an inhibitory effect on the exit of proCD from the Golgi complex prevailed, in PDMP-treated cells an inhibitory effect on the maturation of the intermediate CD form prevailed. To further discriminate the proCD forms resident in the endoplasmic reticulum and in the Golgi complex an aliquot of immuno-precipitates was treated with endoH prior to electrophoresis. This method allows the identification of molecules that bear complex type carbohydrates (resistant to endoH hydrolysis), a hallmark for glycoproteins that have reached the late Golgi compartment, from those that bear high mannose type carbohydrates (sensitive to endoH hydrolysis), i.e. proteins that either have not reached the trans Golgi compartments or have acquired the mannose-6-phosphate group (Braulke et al., 1988; Isidoro et al., 1990) . For simplicity we can refer to secreted proCD, which in control cultures is a mixture of molecules bearing two endoH-sensitive (Pmm, about 75% of total), or one resistant and one sensitive (Pcm), oligosaccharides, whereas in NAS-or PDMP-treated cultures they bear mainly (exclusively) endoH-sensitive sugars. From these data we conclude that ceramide not only retards the exit of proCD from the Golgi complex and the conversion of the intermediate single-chain into the double-chain form of CD, but it also interferes with the Golgi-associated processing of oligosaccharides.
Discussion
In the present work we analysed the temporal relationship between the onset of apoptosis and perturbations of glycoprotein traffic following intracellular accumulation of ceramide. For this purpose we studied the fate of cathepsin D, a lysosomal protease involved in cytokine-dependent apoptosis, in HT-29 colon cancer cells treated under conditions that effectively raised the levels of cellular ceramide. Two main outcomes arise from the present study: (i) NAS and PDMP induce the accumulation of high levels of cellular ceramide and cause the caspase-dependent apoptosis of HT-29 cells; and (ii) NAS and PDMP delay the exit from the Golgi complex and the lysosomal maturation of proCD in a time-and dose-dependent fashion prior to onset of apoptosis.
Ceramide Induces Caspase-Dependent Cell Death of HT-29 Cells
It has been reported that HT-29 cells are rather resistant to apoptotic cell death in response to cytotoxic drugs (Canman et al., 1992) , despite the high expression levels of neutral SMase on the plasma membrane (Kok et al., 1995) . However, in a recent study we have shown that TNFα alone and taxol are both able to induce apoptosis in HT-29 cultures (Cesaro et al., 2001) . Accordingly, in the present study we demonstrated by means of several structural and biochemical analyses the occurrence of apoptotic cell death in HT-29 cells cultivated under conditions that increased their intracellular levels of ceramide. In enterocytic-like differentiated HT-29 rev cells a cytotoxic effect was observed under treatment with NAS (C2-ceramide), but not with PDMP (Veldman et al., 1998) .
Whether ceramide merely accumulates in dying cells or acts as a messenger for cell death is still a controversial question Dixit, 1998, 1999; Kolesnick and Hannun, 1999; Watts et al., 1999) . For instance, Watts and collaborators found that in TNFα-treated cells ceramide levels increased concomitantly or after caspase activa- S]-methionine/cysteine and chased for the time indicated in fresh unlabelled medium with no addition (Co) or in the presence of 100 µM NAS or of 100 µM PDMP. After immuno-precipitation from medium and cell extracts, CD was digested (+) or not (-) with endoH, electrophoresed on a 12.5% polyacrylamide gel under denaturing conditions and revealed by fluorography. CD molecular forms: P, precursor; I, intermediate single-chain; HC, heavy chain of the double-chain form. CD polypeptides bearing complex type (c) or high-mannose type (m) are labelled as follow: Pcm, precursor bearing one complex and one high-mannose type of sugar; Pmm, precursor bearing two high-mannose sugars; Icm, intermediate bearing one complex and one highmannose type of sugar; Imm, intermediate bearing two high-mannose type sugars; HCm, heavy-chain of the double-chain form bearing one high-mannose sugar. Recognition of glycosylated CD forms is based on the shift of molecular weight after EndoH digestion (see also Braulke et al., 1988) . A similar pattern of CD biogenesis and secretion as influenced by NAS or PDMP was observed in two other independent experiments. (B) Densitometric analysis of the fluorography shown in (A). Data expressed as percentage of arbitrary units to show the relative accumulation in cells and medium of the various molecular forms of CD at each chase-point. tion, raising the question of whether these increases in basal ceramide levels were instrumental to the apoptotic process (Watts et al., 1999) . Data presented in the present report indicate that classical morphological and biochemical signs of apoptosis, including DNA fragmentation, appearance of SubG1 peak, and caspase 3-dependent cleavage of PARP, become evident when HT-29 cells are exposed to 100 µM NAS for a period longer than 8 h. Yet, an 8 h treatment with 100 µM NAS was sufficient to cause intracellular accumulation of ceramide. It is striking that PARP was still intact in cells exposed for 8 h to NAS or PDMP, in which endogenous levels of ceramide were 3.5-fold over control levels. Altogether these observations lend support to the view that ceramide increases precede onset of apoptosis and that these increases have to reach an adequate level in order to trigger the 'execution phase' of apoptosis, possibly at the level of the 'death effecter' caspase 3 as suggested by other authors (Mathias et al., 1998; Yoshimura et al., 1998; Sun et al., 1999) .
Ceramide Effects on proCD Transport and Processing Precede the Appearance of Classical Biochemical and Morphological Hallmarks of Apoptosis
The notion that ceramide can affect the transport of glycoproteins relies on studies on transfected cells expressing very high levels of exogenous (viral) proteins (Rosenwald and Pagano, 1993; Maceyka and Machamer, 1997) , a condition that may itself alter the dynamic of inter-organellar traffic. The present study provides the first evidence that increased levels of endogenous ceramide can affect the intracellular transport of endogenous lysosomal glycoproteins. The results show that not only the transit within the Golgi compartments, but also the segregation into the endosomal pathway and the maturation of lysosomal proCD, were negatively influenced by NAS and PDMP, two drugs that raised the intracellular levels of ceramide. Strikingly, ceramide generated by the endosomal acid sphingomyelinase was shown to promote the conversion of proCD into the mature, enzymatically active singlechain and double-chain molecular forms (Heinrich et al., 1999) . Therefore, compartmentalisation influences the consequences of ceramide increases on lysosomal targeting and maturation of proCD. Consistent with this view, the different effects of NAS and PDMP on the kinetic of intermediate CD processing might reflect differences in kinetics and sub-cellular site(s) of ceramide accumulation induced by the two drugs. It is predictable that NAS elicits an increase of the intracellular pool of ceramide more rapidly than PDMP. Finally, the fact that in PDMP-treated cells secreted proCD bears exclusively high mannose-type sugars is suggestive of an (additional) inhibitory effect of PDMP on the machinery for the receptor-mediated segregation into the endosomal-lysosomal pathway. This is possibly related with the prominent accumulation of PDMP in lysosomes (Rosenwald et al., 1992) .
As discussed above, in our model morphological features of apoptosis were apparent no earlier than at 24 h, and biochemical alterations indicative for ongoing apoptosis were detected no earlier than after 8 h, of treatment with NAS or PDMP. Distinct alterations of proCD traffic could be evidenced much earlier (after 2 -4 h of treatment). These observations, while leaving open the possibility that the observed perturbations in CD biogenesis and traffic play a role in cell death induction, clearly rule out that such perturbations may be a consequence of the cell death process. Defining whether and how the apoptotic process and protein traffic are temporally linked will contribute to understanding the molecular mechanisms of apoptosis and to the possible identification of new biochemical markers of the ongoing process. Studies are in progress in our laboratories to confirm whether perturbation of glycoprotein traffic in the secretory pathway can be considered as a general early feature of ongoing apoptosis.
Materials and Methods

Cell Cultures and Treatments
HT-29 cells, derived from a human colon adenocarcinoma, were obtained from ATCC (Rockville, MD, USA) and grown under standard culture conditions (37°C; 95:5 air:CO 2 ratio) in Dulbecco's modified Minimal Essential Medium containing 10% heatinactivated foetal calf serum (Isidoro et al., 1997) . Cells were plated in culture flasks at an initial density of 25 000 cells/cm 2 and allowed to adhere at least 72 h prior to the start of the experiments. By this time cell density reached the approximate value of 150 000 cells/cm 2 . Culture reagents were from Sigma (Milano, Italy). The hydrosoluble ceramide analogues, NAS (active) and DH-C2 (inactive), and the metabolic inhibitor PDMP were purchased from Biomol Research Laboratories Inc.
(Philadelphia, PA, USA). Stock solutions were made in ethanol or DMSO. Control experiments excluded any cellular effect of solvents at the final concentration (0.1 -0.5% v/v) utilised. In some experiments the caspase inhibitors DEVD or ZVAD (Biomol Research Laboratories Inc.) were added concomitantly with NAS or PDMP.
Morphological Evaluation of Cell Death
At the end of incubation adherent cells were trypsinised and counted in triplicate. Cytospins with a total 3×10 4 cells from treated cultures (a mixture of adherent and detached cells) were prepared by centrifugation at 200 g for 10 min in a cyto-centrifuge. Morphology of necrotic and apoptotic cells was evaluated by light phase-contrast microscopy of haematoxylin-eosinstained cells (Bonelli et al., 1996) .
Cytofluorometric Assessment of Cell Death
10 6 adherent and detached cells were pooled, collected by centrifugation (300 g for 15 min), washed twice with cold PBS and fixed in ice-cold 70% ethanol for 1 h at 4°C. The cells were washed twice with PBS and incubated for 30 min at room temperature in the dark with RNase A (0.4 mg/ml) and propidium iodide (0.18 mg/ml) in 1 ml final volume PBS. In some instances cells were not ethanol-fixed prior to incubation with propidium iodide. In this case only necrotic cells could be labelled in their DNA moiety. Cell cycle analysis was performed with a FacScan flow cytometer (Becton Dickinson, Mountain View, CA, USA) equipped with a 488 nm argon laser. Cells with a hypo-diploid content of DNA (subG0/G1 peak) were assumed as apoptotic (Nicoletti et al., 1991) . Concomitant Annexin V-FITC/propidium iodide staining of non-fixed cells was performed in calcium-containing medium essentially as described by Vermes et al. (1995) using the 'early apoptosis' detection kit from Bender MedSystems (Vienna, Austria). Samples were measured by FITC/propidium iodide flow cytometry. Data were recorded and interpreted with a Hewlett Packard computer (HP 9000, model 300) equipped with the CellFit software (Becton Dickinson). At least 10 000 events were analysed for each sample.
DNA Inter-Nucleosomal Fragmentation Assay
Adherent and detached cells were pooled, re-suspended in lysis buffer (500 mM Tris-HCl pH 9.0, 10 mM EDTA, 10 mM NaCl, 1% sodium lauryl sulphate, 200 µg/ml proteinase K) and incubated for 2 h at 48°C in the presence of RNAse A (400 µg/ml). Samples were extracted twice with phenol/chloroform (v/v) and precipitated overnight in 2.5 vol of absolute ethanol at -20°C. DNA was recovered by centrifugation at 4°C (13 000 g for 20 min) and the pellet washed once with 70% ethanol, dried and finally dissolved in 10 mM Tris-HCl pH 7.4, 1 mM EDTA. Aliquots of each sample corresponding to 25 µg DNA were supplemented with loading buffer containing ethidium bromide and separated electrophoretically in 1.4% agarose gels. DNA bands were visualised and photographed under a UV transilluminator.
Immunoblotting Assay of PARP Cleavage and of Cytochrome C Release from Mitochondria
For PARP cleavage assay, 10 6 cells were lysed in sample buffer (62.5 mM Tris/HCl pH 6.8, 6 M urea, 10% glycerol, 2% SDS, 0.00125% bromophenol blue, 5% β-mercaptoethanol), sonicated and incubated for 15 min at 65°C. Equal volumes of samples were separated by electrophoresis on a 7.5% polyacrylamide/0.1% SDS gel and electro-blotted onto a nitrocellulose filter. Ponceau Red staining of the filter confirmed the homogeneity of protein loading among the different lanes. Immunostaining of albumin-saturated filters was performed with a rabbit polyclonal anti-PARP antiserum (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) followed by goat anti-rabbit IgG conjugated with horseradish peroxidase (Bio-Rad, Milano, Italy). Protein bands were revealed by chemiluminescence reaction (DuPont NEN, Boston, MA, USA). For the cytochrome c release assay, 1.5×10 6 cells were gently re-suspended in sucrose-containing buffer (250 mM sucrose, 20 mM Hepes, 1 mM EDTA, pH 7.2, 1 mM phenylmethylsulfonyl fluoride, 5 mM iodoacetamide), homogenised by passing the cells through a 25-gauge needle and mitochondrial and cytosolic fractions separated by centrifugation at 100 000 g for 15 min at 4°C (Tepper et al., 1999) . Cytochrome c was revealed by Western blotting as outlined above using anti-cytochrome c monoclonal antibody (PharMingen, San Diego, CA, USA) as the primary antibody followed by goat anti-mouse IgG conjugated with peroxidase (Bio-Rad).
Analysis of CD Transport and Processing
For protein detection on immunoblots, cell homogenates were prepared in 0.25% sodium desoxycholate by several freezethawing cycles and sonication. Protein concentration was determined by the method of Lowry et al. (1951) , using bovine serum albumin as the standard. Aliquots of cell homogenates corresponding to 30 µg of protein were heat-denatured in sampleloading buffer, separated by gel electrophoresis (12.5% polyacrylamide, 0.1% SDS) and electro-blotted onto Hybond-C Extra nitrocellulose sheets (Amersham, Buckinghamshire, UK). The filter was stained with Ponceau Red to ascertain equal loading and transfer of proteins among lanes. Albumin-saturated filters were hybridised with polyclonal rabbit anti-CD antibody (Isidoro et al., 1997) was performed in methionine/cysteine-deficient medium as described previously (Isidoro et al., 1997) . CD was immuno-precipitated from cell extracts and media with purified polyclonal rabbit anti-CD IgG followed by protein A-Sepharose and immuno-precipitates washed, denatured and analysed by electrophoresis and fluorography as described previously (Isidoro et al., 1990) . In some instances, aliquots of the immuno-precipitates were treated with 1 unit of endoH (Boehringer Mannheim, GmbH, Germany) prior to electrophoresis (Isidoro et al., 1991) .
Measurement of Cellular Ceramide Level
Ceramide was quantitated using an improved E. coli diacylglycerol kinase (DAG-K) assay essentially according to previously described methods (Preiss et al., 1986 , Van Veldhoven et al., 1989 Perry and Hannun, 1999) . 2×10 6 cells were collected in methanol and lipids extracted by the method of Bligh and Dyer (1959) . One ml and 0.3 ml of the organic phase were dried and used for ceramide and inorganic phosphate measurements, respectively (Ames et al., 1966) . 30 nmol of lipids were incubated at room temperature for 45 min with E.coli DAG-K (5 µg membrane proteins) in the presence of β-octylglucoside/dioleoylphosphatidylglycerol micelles, 2 mM dithiothreitol and 1 mM ATP (mixed with γ-[P 32 ] ATP at a final concentration of 0.013 µCi/µl) in a final volume of 100 µl. Lipids were then extracted and dissolved in 80 µl of chloroform:methanol (1:1). One quarter of the reaction products was separated by thin layer chromatography in chloroform:acetone:methanol:acetic acid:water (10:4:3:2:1, v/v). Following overnight autoradiography, specific radioactivity of ceramide-1-phosphate was determined by scintillation counting of corresponding spots scraped off the gel. Cellular ceramide levels were determined by comparison of the experimental values with a linear standard curve of known amounts of ceramide. Quantitative results are normalised to inorganic phosphate. To quantify inorganic phosphate, lipid samples were supplemented with 0.6 ml of 10 N H 2 SO 4 :70% HClO 4 :H 2 O (9:1:40, v/v) and incubated overnight at 157°C. The samples were then supplemented with 100 µl distilled H 2 O, 0.5 ml 0.9% ammonium molybdate and 0.2 ml 9% ascorbic acid and further incubated for 30 min at 45°C. A NaH 2 PO 4 standard was prepared in a similar manner. Absorbance was read at 820 nm.
